[HTML][HTML] LRRK2 and the Endolysosomal System in Parkinson's Disease

ML Erb, DJ Moore - Journal of Parkinson's disease, 2020 - content.iospress.com
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal dominant familial
Parkinson's disease (PD), with pathogenic mutations enhancing LRRK2 kinase activity …

[PDF][PDF] LRRK2 and the Endolysosomal System in Parkinson's Disease

ML Erb, DJ Moore - scholar.archive.org
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal dominant familial
Parkinson's disease (PD), with pathogenic mutations enhancing LRRK2 kinase activity …

LRRK2 and the Endolysosomal System in Parkinson's Disease

ML Erb, DJ Moore - Journal of Parkinson's Disease, 2020 - content.iospress.com
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal dominant familial
Parkinson's disease (PD), with pathogenic mutations enhancing LRRK2 kinase activity …

[HTML][HTML] LRRK2 and the Endolysosomal System in Parkinson's Disease

ML Erb, DJ Moore - Journal of Parkinson's Disease, 2020 - ncbi.nlm.nih.gov
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal dominant familial
Parkinson's disease (PD), with pathogenic mutations enhancing LRRK2 kinase activity …

LRRK2 and the Endolysosomal System in Parkinson's Disease.

ML Erb, DJ Moore - Journal of Parkinson's Disease, 2020 - europepmc.org
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal dominant familial
Parkinson's disease (PD), with pathogenic mutations enhancing LRRK2 kinase activity …

[PDF][PDF] LRRK2 and the Endolysosomal System in Parkinson's Disease

ML Erb, DJ Moore - Journal of Parkinson's Disease, 2020 - pdfs.semanticscholar.org
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal dominant familial
Parkinson's disease (PD), with pathogenic mutations enhancing LRRK2 kinase activity …

[HTML][HTML] LRRK2 and the Endolysosomal System in Parkinson's Disease

ML Erb, DJ Moore - Journal of Parkinson's disease, 2020 - ncbi.nlm.nih.gov
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal dominant familial
Parkinson's disease (PD), with pathogenic mutations enhancing LRRK2 kinase activity …